Michael G. Ison, MD MS
@michaelisonmd.bsky.social
Transplant Infectious Diseases MD, clinical respiratory virologist and Editor-in-Chief of @TheTxIDJournal.bsky.social.
All opinions and tweets are my own.
All opinions and tweets are my own.
It’s pretty standard practice and great move for transparency.
May 27, 2026 at 12:05 PM
It’s pretty standard practice and great move for transparency.
Reposted by Michael G. Ison, MD MS
Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3...
3/3
3/3
ESGICH ESCMID Global 2027 Session Concept Submission Form
Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.
forms.gle
March 21, 2026 at 9:09 PM
Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3...
3/3
3/3
Reposted by Michael G. Ison, MD MS
Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH...
2/3
2/3
ESGICH Planning Committee for 2027 ESCMID Global
This will be a small working group to help develop proposals for ESGICH to propose for the 2027 ESCMID Global Program.
The group will brainstorm in person at ESCMID Global in Munich:
Sunday April 1...
forms.gle
March 21, 2026 at 9:08 PM
Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH...
2/3
2/3
Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3...
3/3
3/3
ESGICH ESCMID Global 2027 Session Concept Submission Form
Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.
forms.gle
March 21, 2026 at 9:09 PM
Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3...
3/3
3/3
Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH...
2/3
2/3
ESGICH Planning Committee for 2027 ESCMID Global
This will be a small working group to help develop proposals for ESGICH to propose for the 2027 ESCMID Global Program.
The group will brainstorm in person at ESCMID Global in Munich:
Sunday April 1...
forms.gle
March 21, 2026 at 9:08 PM
Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH...
2/3
2/3
But worth it for piece of mind.
December 12, 2025 at 8:36 AM
But worth it for piece of mind.
It’s actually hard to get the vaccine - we got ours but it required pre-paying for the doses and having delays in getting them delivered to the pharmacy. Total cost $900 with GoodRx and 3 doses so takes time. Doable but expensive and takes a lot of effort to arrange (in my experience).
December 12, 2025 at 8:36 AM
It’s actually hard to get the vaccine - we got ours but it required pre-paying for the doses and having delays in getting them delivered to the pharmacy. Total cost $900 with GoodRx and 3 doses so takes time. Doable but expensive and takes a lot of effort to arrange (in my experience).
Important Ongoing Studies where we have or will have publications soon:
Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...
CD388 for prevention of influenza: www.cidara.com/news/cidara-...
Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...
CD388 for prevention of influenza: www.cidara.com/news/cidara-...
Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Herpes Simplex Virus-infected Patients in Phase 3 Pivotal Trial - Aicuris
Aicuris today announced that the Phase 3 trial of its lead candidate pritelivir has met its primary and secondary endpoint. The aim of the trail was to evaluate
www.aicuris.com
October 22, 2025 at 1:40 PM
Important Ongoing Studies where we have or will have publications soon:
Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...
CD388 for prevention of influenza: www.cidara.com/news/cidara-...
Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...
CD388 for prevention of influenza: www.cidara.com/news/cidara-...
Results from season 3 of the GSK RSV Vaccine (NOTE - I was the lead author so I’m biased on this one)
www.thelancet.com/journals/lan...
Two trials on tecovirimat for Mpox and the need to consider research in context of EUA medications
www.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
Two trials on tecovirimat for Mpox and the need to consider research in context of EUA medications
www.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSV...
A single RSVPreF3 OA dose was efficacious against RSV-LRTD over three RSV seasons
in people aged 60 years or older, despite a decrease in efficacy over time. Further
research is needed to establish th...
www.thelancet.com
October 22, 2025 at 1:39 PM
Results from season 3 of the GSK RSV Vaccine (NOTE - I was the lead author so I’m biased on this one)
www.thelancet.com/journals/lan...
Two trials on tecovirimat for Mpox and the need to consider research in context of EUA medications
www.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
Two trials on tecovirimat for Mpox and the need to consider research in context of EUA medications
www.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....
Study of baloxavir to prevent household transmission of influenza
www.nejm.org/doi/full/10....
Two studies of monoclonals for RSV prevention
www.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
www.nejm.org/doi/full/10....
Two studies of monoclonals for RSV prevention
www.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | NEJM
Baloxavir marboxil (baloxavir) rapidly reduces influenza virus shedding, which suggests that it may reduce transmission. Studies of treatment with neuraminidase inhibitors have not shown sufficient...
www.nejm.org
October 22, 2025 at 1:38 PM
Study of baloxavir to prevent household transmission of influenza
www.nejm.org/doi/full/10....
Two studies of monoclonals for RSV prevention
www.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
www.nejm.org/doi/full/10....
Two studies of monoclonals for RSV prevention
www.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
Two trials on lenacapravir for prevention of HIV
www.nejm.org/doi/full/10....
www.nejm.org/doi/10.1056/...
Two trials on high dose influenza vaccine
jamanetwork.com/journals/jam...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/full/10....
www.nejm.org/doi/10.1056/...
Two trials on high dose influenza vaccine
jamanetwork.com/journals/jam...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/abs/10.1...
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM
Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of human immunodeficiency virus (HIV) infection in cisgender women. The efficacy of lenacapavir for preexposure...
www.nejm.org
October 22, 2025 at 1:37 PM
Two trials on lenacapravir for prevention of HIV
www.nejm.org/doi/full/10....
www.nejm.org/doi/10.1056/...
Two trials on high dose influenza vaccine
jamanetwork.com/journals/jam...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/full/10....
www.nejm.org/doi/10.1056/...
Two trials on high dose influenza vaccine
jamanetwork.com/journals/jam...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/abs/10.1...